Webinar
Bringing Drugs to Clinics Faster with NVIDIA Computing
In the last decade, there have been dramatic advances in the field of computer-aided drug discovery. Researchers can now better understand causal biology, more effectively search through chemical space, and design de novo molecules that aim to treat disease.
Content goes here
content goes here
Content goes here
Content goes here
Sathesh Bhat joined Schrödinger in 2011. He is responsible for overseeing computational chemistry efforts on internal and partnered drug discovery programs at Schrödinger. Previously, Sathesh worked at both Merck and Eli Lilly leading computational efforts in several drug discovery programs. He obtained his Ph.D. from McGill University, which involved developing structure-based methods to predict binding free energies. Sathesh has co-authored multiple patents and publications and continues to publish on a wide variety of topics in computational chemistry.
Rory Kelleher is responsible for NVIDIA’s worldwide go-to-market strategy for bringing accelerated computing and artificial intelligence into life sciences, drug discovery, and healthcare markets. He leads a team of professionals operating at the intersection of science, technology and business to align with industry leaders and apply transformational computational approaches across the healthcare and life sciences landscape. Kelleher joined NVIDIA in 2016 leading the Healthcare business for the Eastern US, helping organizations tap into the NVIDIA ecosystem and expertise to adopt, develop, and deploy intelligent and accelerated applications. Prior to NVIDIA, Kelleher spent a decade in business development and sales leadership positions at technology firms Cisco Systems and EMC Corp.
PRESENTER 3 BIO
Presenter 4 Bio
Content here
Webinar: Description here
Date & Time: Wednesday, April 22, 2018